Litiasis Renal

The PREVENTLIT study shows that Lit-Control® reduces new episodes of renal lithiasis

Devicare is presenting the positive results of the PREVENTLIT clinical study today which have been published in Clinical Medicine Insights Urology. The results show the efficacy and tolerance of its products Lit-Control® pH Up and Lit-Control® pH Down to regulate urinary pH in patients with renal lithiasis. The study confirms that maintaining urinary pH within […]

The IMB-CNM-CSIC has successfully passed the inspection from the AEMPS and will now be an authorised sub-contractor for Devicare

July 11, 2019

The Microelectronic Institute of Barcelona-National Microelectronic Centre (IMB-CNM), one of Devicare’s leading suppliers, has successfully passed an inspection of its facilities by the Spanish Agency of Medicines and Medical Devices (AEMPS). The ICB-CNM is now accredited as an authorised sub-contractor by the AEMPS to carry out its activity in the medical devices sector.

The plan […]

Devicare signs three business agreements for Lit-Control® in Europe and North Africa

Device continues its international expansion, positioning its brand as a benchmark in innovative therapeutic solutions in urology. After taking the leap into the US market in May, the company has signed three new agreements to market Lit-Control® in the United Kingdom, Malta and Algeria. In total, Devicare is now present in 34 countries.

The partners in […]

Devicare obtiene 500.000 euros adicionales de la línea Innova Global de Avançsa

Devicare ha firmado un nuevo préstamo participativo de 500.000 euros de la línea Innova Global de Avançsa, adscrita al Departamento de Empresa y Conocimiento, para acelerar el crecimiento internacional de la compañía que desarrolla nuevas soluciones terapéuticas en urología.

En 2017 Avançsa ya apostó por este proyecto empresarial aportando una financiación de 2 millones de euros tras valorar su alto potencial […]

Devicare abre una ronda de ‘crowdfunding’ de 1,5 millones de euros


29 Mayo 2019

Devicare quiere acelerar su crecimiento y para ello ha puesto en marcha una campaña de crowdfunding de 1,5 millones de euros en la plataforma Capital Cell. En una semana ya se ha conseguido el 39% del objetivo. La cantidad mínima a invertir es 1.000 euros.

Devicare ha desarrollado una solución para el tratamiento […]

Devicare launches Lit-Control® in the US with Diem Labs






May 5th, 2019

Devicare is taking the leap into the US healthcare market with its new partner Diem Labs, LLC to introduce an innovative digital medical solution (DTx) in the urology field in the country.

The official launch of Lit-Control® take place in the American Urological Association Annual Meeting (BOOTH 3440), held from 3 to 6 May in […]

Devicare is preparing the largest round of crowdfunding on Capital Cell

May 3rd, 2019

Devicare is aiming to speed up its growth and will start a 1.5 million Euro crowdfunding round on Capital Cell, the funding platform that specialises in healthcare. With a 1,000 Euro minimum ticket, the company is looking to attract small investors, sponsors, patients and people knowledgeable about innovation and health.

Devicare is a technologically-driven […]

Devicare participates in the leading lithiasis event in Spain and presents the results of the ‘Double J’ trial

February 7th, 2019

Devicare participated in the National Meeting of the Lithiasis, Endourology, Laparoscopy and Robotics Groups (LELR), held on 24 and 25 January in Palma de Mallorca. The plenary sessions focused on the medical and surgical handling of urinary lithiasis which affects 10% of the Spanish population. The final results of the “Double J” clinical […]

The ‘Double J’ clinical trial wins the Pedro Arregui award from the Spanish Urological Association

February 5th, 2019

During the 19th National Meeting of the Lithiasis, Endourology and Robotics Groups organised by the Spanish Urological Association on 24 and 25 January in Palma de Mallorca, Dr Jaime Fernández-Concha was recognised on behalf of the research team for the Multicenter, Controlled and Randomized clinical trial on urinary pH monitoring and nutraceutical intervention […]

Devicare announces the positive results of the clinical trial with Lit-Control® to prevent the encrustation of catheters in patients with lithiasis

Devicare and nine leading Spanish hospitals in urology have successfully completed the clinical trial which demonstrates the efficacy of the combined use of a medical device (Lit-Control® pH Meter) and a nutraceutical (Lit-Control® pH Down) to prevent the encrustation of double J catheters by monitoring urinary pH and supplying phytates (crystallisation inhibitors).

The results of this […]